Titre : | Case Report: Presumed Optic Neuropathy after Amiodarone and then Dronedarone for Treatment of Atrial Fibrillation |
Type de document : | article de périodique |
Auteurs : | Idit Maharshak ; Michael Paul ; Hillel Steiner |
Année de publication : | 2020 |
Langues : | Français (fre) |
Descripteurs (mots clés) : | [Thésaurus Mesh]Amiodarone [Thésaurus Mesh]Atteintes du nerf optique [Thésaurus Mesh]Effets secondaires indésirables des médicaments [Thésaurus Mesh]Maladies du système nerveux [Thésaurus Mesh]Oeil [Thésaurus Mesh]Troubles de la vision [Thésaurus HELB]:Paramédical:dronédarone
|
Résumé : | SIGNIFICANCE: Amiodarone and dronedarone have recognized ophthalmological adverse effects including optic
neuropathy. The recognition of optic neuropathy as a complication of amiodarone and dronedarone treatment
may enable withdrawing the drug and accordingly preventing permanent vision loss.
PURPOSE: This study aimed to describe a case of optic neuropathy after substitution of amiodarone with
dronedarone for treatment of atrial fibrillation.
CASE REPORT: An 81-year-old man treated with dronedarone for atrial fibrillation after amiodarone had caused
tremor developed sequential permanent vision loss in both eyes.
CONCLUSIONS: The importance of timely recognition of optic neuropathy as a complication of amiodarone and
dronedarone treatment may enable discontinuing the drug, thus preventing permanent vision loss. |
Note de contenu : | Idit Maharshak, MD, PhD,1,2 Michael Paul, MD,1,2 and Hillel Steiner, MD2,3*
|
Permalink : | https://bibliotheque.helb-prigogine.be/opac_css/index.php?lvl=notice_display&id= |